Quest Partners LLC Has $26,000 Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Quest Partners LLC trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 89.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,190 shares of the pharmacy operator’s stock after selling 19,182 shares during the quarter. Quest Partners LLC’s holdings in Walgreens Boots Alliance were worth $26,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Atlas Brown Inc. raised its position in shares of Walgreens Boots Alliance by 1.8% in the first quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator’s stock valued at $685,000 after purchasing an additional 550 shares during the period. Shilanski & Associates Inc. lifted its position in Walgreens Boots Alliance by 5.3% during the 1st quarter. Shilanski & Associates Inc. now owns 11,821 shares of the pharmacy operator’s stock worth $256,000 after acquiring an additional 591 shares during the last quarter. First Trust Direct Indexing L.P. lifted its position in Walgreens Boots Alliance by 1.9% during the 1st quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock worth $696,000 after acquiring an additional 597 shares during the last quarter. CreativeOne Wealth LLC boosted its holdings in Walgreens Boots Alliance by 7.3% during the fourth quarter. CreativeOne Wealth LLC now owns 10,124 shares of the pharmacy operator’s stock valued at $264,000 after acquiring an additional 688 shares during the period. Finally, Buckley Wealth Management LLC grew its position in shares of Walgreens Boots Alliance by 2.1% in the first quarter. Buckley Wealth Management LLC now owns 37,335 shares of the pharmacy operator’s stock valued at $810,000 after purchasing an additional 785 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on WBA. UBS Group decreased their target price on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a research note on Wednesday, July 3rd. Bank of America cut their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Morgan Stanley dropped their price objective on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a report on Friday, June 28th. Royal Bank of Canada cut their price objective on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 2nd. Finally, Truist Financial decreased their target price on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a research report on Friday, June 28th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $14.73.

Walgreens Boots Alliance Trading Down 3.0 %

WBA stock opened at $8.71 on Friday. Walgreens Boots Alliance, Inc. has a 1-year low of $8.46 and a 1-year high of $27.05. The firm has a market cap of $7.52 billion, a P/E ratio of -1.29, a P/E/G ratio of 1.02 and a beta of 0.70. The business’s 50 day moving average is $10.29 and its 200-day moving average is $14.77. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company had revenue of $36.40 billion during the quarter, compared to analyst estimates of $35.94 billion. During the same period in the prior year, the firm earned $1.00 EPS. Walgreens Boots Alliance’s quarterly revenue was up 2.8% compared to the same quarter last year. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 11.48%. The ex-dividend date was Wednesday, August 21st. Walgreens Boots Alliance’s payout ratio is -14.84%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.